相关实验视频

Updated: Jul 26, 2025

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization

Published on: December 23, 2020

SARS-CoV-2 nsp13 限制长期DNA转录而不影响染色体DNA

Aixin Li^1,2, Bei Zhang¹, Kaitao Zhao¹

¹State Key Laboratory of Virology and Hubei Province Key Laboratory of Allergy and Immunology, Hubei Jiangxia Laboratory, Institute of Medical Virology, TaiKang Center for Life and Medical Sciences, TaiKang Medical School, Wuhan University, Wuhan, China.

Journal of virology

|June 22, 2023

概括

在SARS-CoV-2中,非结构性蛋白13 (nsp13) 特别抑制了情节性DNA转录. 这一发现导致了一种新的,具有成本效益的高通量药物查方法,用于开发针对COVID-19的新型抗病毒疗法.

科学领域:

病毒学和分子生物学
抗病毒药物开发抗病毒药物开发

背景情况:

SARS-CoV-2非结构蛋白13 (nsp13) 是一种对病毒复制至关重要的螺旋酶,也是潜在的抗病毒标.
最初的研究探讨了nsp13与干扰素 (IFN) 信号通路的相互作用.

研究的目的:

阐明SARS-CoV-2 nsp13影响基因转录的特定机制.
开发一种新,高效的高通量药物查方法,针对nsp13进行抗病毒药物发现.

主要方法:

研究了nsp13对IFN-β促进剂试验和RIG-I/MDA5通路中的记者基因表达的影响.
通过转染和整合模型评估nsp13对插曲性与染色体基因表达的影响.
利用截断/突变的nsp13形式,流量转录试验,RNA测序,并开发了一种药物查试验.

主要成果:

SARS-CoV-2 nsp13 特别抑制了情节性 DNA 转录,而不是染色体 DNA 转录.
对于这种抑制,nsp13的NTPase和helicase活动以及直接结合发发发性DNA是必不可少的.
一种具有成本效益和方便的高通量药物查方法,针对nsp13,已成功开发和验证.

结论:

SARS-CoV-2 nsp13 具有独特的能力,可以通过其酶功能来抑制病例性基因转录.
开发的高通量选系统有助于发现强效和选择性的NSP13抑制剂.
这项研究有助于了解SARS-CoV-2复制,并加速新抗病毒疗法的开发.

关键词:

这就是SARS-CoV-2病毒.药物查对药物进行查.病期性DNA是指发生病期性的DNA.在NSP13中使用.

更多相关视频

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

Gene Digital Circuits Based on CRISPR-Cas Systems and Anti-CRISPR Proteins

Gene Digital Circuits Based on CRISPR-Cas Systems and Anti-CRISPR Proteins

Published on: October 18, 2022

相关概念视频

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...

Eukaryotic Transcription Inhibitors

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...

Viruses with RNA Genomes

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...

Epigenetic Regulation

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...

siRNA - Small Interfering RNAs

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...

Restriction Enzymes

Restriction Enzymes

Restriction enzymes are bacterial enzymes used to cut DNA in a sequence-specific manner. To cleave DNA, they bind to specific palindromic sequences called restriction sites. Such palindromic DNA sequences or inverted repeats are commonly found in regions of functional significance, such as the origin of replication, gene operator sites, and regions containing transcription termination signals.
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...